Live Markets, Charts & Financial News

Sen. Warren accuses GSK of price gouging over pediatric asthma drug (NYSE:GSK)

0 44

William Barton

U.S. Sen. Elizabeth Warren has slammed GSK (NYSE:GSK) for alleged price-gouging over the marketing of its pediatric asthma drug Flovent HFA and its authorized generic.

In a statement released Monday, Warren accused GSK of discontinuing the branded version of the product “in

Leave A Reply

Your email address will not be published.